$SYRS Syros Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Syros Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Syros Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Syros Pharmaceuticals, Inc. for free.
IRS Number: 453772460
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: SYRS
Company Address: 35 CAMBRIDGE PARK DRIVE CAMBRIDGE 02140
Phone number: 617-744-1340
Former name: LS22, Inc., date of change: 2012-08-15
Market Capitalization: $249.93M
Prev close: $10.92
Average Daily Volume: 22,044
Days Low: $10.53
Year Low: $8.16
Year High: $21.50
Syros Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 2021 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | M | 1.01 | 3,628 | 3,664 | 90,697 | |
| Mar 17 2021 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Sell | S | 9.47 | 3,628 | 34,372 | 0 | 3.6 K to 0 (-100.00 %) |
| Mar 17 2021 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Buy | M | 1.01 | 3,628 | 3,664 | 3,628 | 0 to 3.6 K |
| Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Springhorn Jeremy P. | Chief Business Offi ... | Option Exercise | A | 11.41 | 94,000 | 1,072,540 | 94,000 | |
| Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Olson Eric R | Chief Scientific Of ... | Option Exercise | A | 11.41 | 94,000 | 1,072,540 | 94,000 | |
| Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Roth David | Chief Medical Offic ... | Option Exercise | A | 11.41 | 119,000 | 1,357,790 | 119,000 | |
| Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Ferra Joseph J Jr | Chief Financial Off ... | Option Exercise | A | 11.41 | 119,000 | 1,357,790 | 119,000 | |
| Feb 19 2021 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | A | 11.41 | 304,000 | 3,468,640 | 304,000 | |
| Feb 18 2021 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 12.05 | 3,750 | 45,188 | 321,711 | 325.5 K to 321.7 K (-1.15 %) |
| Feb 10 2021 | SYRS | Syros Pharmaceutic ... | Young Richard A | Director | Sell | S | 13.04 | 3,750 | 48,900 | 325,461 | 329.2 K to 325.5 K (-1.14 %) |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 10.09 | 4,988 | 50,329 | 280,012 | |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 8.51 | 14,168 | 120,570 | 79,165 | |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Option Exercise | M | 3.04 | 10,761 | 32,713 | 21,524 | |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 10.09 | 4,988 | 50,329 | 563,606 | 558.6 K to 563.6 K (+0.89 %) |
| Dec 21 2020 | SYRS | Syros Pharmaceutic ... | Simonian Nancy A | President & CEO | Buy | M | 8.51 | 14,168 | 120,570 | 558,618 | 544.5 K to 558.6 K (+2.60 %) |